Timothy Ives

Document Actions
PUBLICATIONS

Publications

 

Refereed Journals:

 

1.                   Ives TJ, Pevonka MP, Andresen BD, and Yost RL.  Effect of methyldopa on urine glucose test methods.  Am J Hosp Pharm.  1980; 37: 683-7.

 

2.                   Ives TJ and Heath R.  Letter:  Amitriptyline‑induced tonic‑clonic seizures in the mentally retarded.  Drug Intell Clin Pharm.  1980; 14: 378.

 

3.                   Ives TJ.  Illicit use of diphenoxylate hydrochloride to prevent narcotic withdrawal symptoms.  Drug Intell Clin Pharm. 1980; 14: 715‑6.

 

4.                   Ives TJ and Stewart RB.  Doxepin‑induced acute glossitis.  Am J Hosp Pharm. 1980; 37: 1551‑2.

5.                   Ives TJ.  Letter: Doctor of Pharmacy degrees.  Am Fam Phys.  1981; 24: 25‑8.

 

6.                   Huff PS, Ives TJ, Almond SN and Griffin NW.  Pharmacist‑managed diabetes education service.  Am J Hosp Pharm. 1983; 40: 991‑4.

 

7.                   Ives TJ.  Use of dimenhydrinate hydrochloride in the treatment of green tobacco sickness.  Drug Intell Clin Pharm.  1983; 17: 548‑9.

 

8.                   Ives TJ and Stults CC.  Short‑course diphenoxylate hydrochloride for treatment of methadone withdrawal symptoms.  Brit J Psychiatry.  1983; 143: 513‑4.

 

9.                   Guerra MF and Ives TJ.  Bethanechol‑induced hypothermia.  Ann Intern Med.  1983; 99: 279‑80.

 

10.               Ives TJ.  Human insulin.  U.S. Pharm.  1984; 9: 49‑58.

 

11.               Ives TJ, Parry JL and Gwyther RE.  Serum drug level utilization review in a family medicine residency program.  J Fam Pract.  1984; 19: 507‑12.

 

12.               Ives TJ, Fleming MF, Weart CW and Bloch D.  Treatment of intractable hiccups with intramuscular haloperidol.  Am J Psychiatry.  1985; 142: 1368-9.

 

13.               Patterson JH, Ives TJ and Greganti MA.  Transient bilateral pupillary dilation from scopolamine discs.  Drug Intell Clin Pharm.  1986; 20: 986-7.

 

14.               Ives TJ, Frey JJ, Furr SJ and Bentz EJ.  Effect of an educational intervention on oral cephalosporin use in primary care.  Arch Intern Med.  1987; 147: 44-7.

 

15.               Ives TJ, Bentz EJ and Gwyther RE.  Drug-related admissions to a family medicine inpatient service.  Arch Intern Med. 1987; 147: 1117-20.

 

16.               Lownes HE and Ives TJ.  Mexiletine use in pregnancy and lactation.  Am J Obstet Gynecol.  1987; 157: 446-7.

 

17.               Ives TJ and Guerra MF.  Constant morphine infusion for sickle cell crisis pain.  Drug Intell Clin Pharm.  1987; 21: 625-7.

 

18.               Baldwin JN, Bennett RW, Ives TJ, Miederhoff PA and Tommasello AC.  American Association of Colleges of Pharmacy guidelines for the development of chemical impairment policies for colleges of pharmacy.  Am J Pharm Educ.  1988; 52: 298-304.

 

19.               Ives TJ.  University of North Carolina School of Pharmacy addiction assistance and education programs.  Carolina J Pharm.  1989; 69: 11-2.  (Non-refereed)

 

20.               Ives TJ.  Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.  Diabetes Spectrum.  1989; 2: 304-5.

 

21.               Ives TJ and Stults CC.  Pharmacy practice in a chemical-dependency treatment center.  Am J Hosp Pharm.  1990; 47: 1080-3.

22.               Ives TJ, Dunn PF and Pathman DE.  The nutritional content of pharmaceutical company promotions.  Family Med.  1990; 22: 338-9.

 

23.               Ives TJ and Tepper RS.  Drugs in pregnancy and lactation.  Primary Care.  1990; 17: 623-45.

 

24.               Ives TJ, Mooney AJ and Gwyther RE.  Phenobarbital in the treatment of the alcohol withdrawal syndrome.  South Med J.  1991; 84: 18-21.

 

25.               Ives TJ.  Letter.  Treatment of alcohol withdrawal.  South Med J.  1991; 84: 935-6.

 

26.               Ives TJ and Tepper RS.  Failure of a tapering dose of oral methylprednisolone to treat reactions to poison ivy.  JAMA.  1991; 266: 1362.

 

27.               Ives TJ.  Professional development and clinical specialization in chemical dependency pharmacy practice.  J Pharm Pract.  1991; 4: 380-5.

 

28.               Baldwin JN, Light KE, Stock C, Ives TJ, Crabtree BL, Miederhoff PA, Tommasello T and Levine PJ.  Suggested curricular guidelines for pharmacy education:  Substance abuse and addictive disease.  Am J Pharm Educ.  1991; 55: 311-6.

 

29.               Ives TJ and McDermott JH.  Chemical dependency residency program offered to pharmacists.  Epikrisis.  1992; 2: 1.  (Non-refereed)

 

30.               Ives TJ.  Benzoyl peroxide.  Am Pharm.  1992; NS32: 637-42.

 

31.               Ives TJ, Bentz EJ and Gwyther RE.  Dermatologic adverse drug reactions in a family practice center.  Arch Fam Med.  1992; 1: 241-5.

 

32.               Rose LA, DeVellis BM and Ives TJ.  Prescription medicines.  N Carolina Med J.  1992; 53:  589-92.

 

33.               Walker EA and Ives TJ.  Pharmacy in evolution.  Diabetes Spectrum.  1993; 6: 156.

 

34.               Ives TJ and Goldstein AO.  Letter:  Tobacco and drug use.  J Fam Pract.  1994; 39: 11.

 

35.               Tepper RS, Ives TJ and Kebede M.  Recurrent bacterial vaginosis unresponsive to metronidazole: successful treatment with clindamycin.  J Am Board Fam Pract.  1994; 7: 431-2.

 

36.               Goldstein AO and Ives TJ.  Letter:  Depression treatment.  J Fam Pract.  1994; 39: 114-6.

 

37.               Ives TJ, Lockamy AF, McDermott JH and Brooks VG.  Expanding pharmacy roles in programs on alcohol and other drug abuse.  Am Pharm.  1994; NS34: 52-7.

 

38.               Linn W, Carter BL, Ellsworth A, Ives TJ, Carlisle B, Maddux S and Tabor P.  ACCP White Paper: Guidelines for establishing and evaluating clinical pharmacy services in primary care.  Pharmacotherapy. 1994; 14: 743-58.

 

39.               Goldstein AO and Ives TJ.  Letter:  Pharmacoeconomic considerations in pharmaceutical company promotions.  Arch Fam Med.  1994; 3: 1034-5.

 

40.               Goldstein AO and Ives TJ.  Letter:  OTC nicotine gum.  J Fam Pract.  1995; 40: 15-7.

 

41.               Sloane PD and Ives TJ.  Editorial:  Improving the well-being of nursing home residents.  J Am Board Fam Pract.  1995; 8: 249-50.

 

42.               Ives TJ and Goldstein AO.  Letter:  Pharmacotherapeutic comparisons found in pharmaceutical company promotions.  Arch Fam Med.  1995; 4: 674-5.

 

43.               Ives TJ, Manzewitsch P, Regnery RL, Butts JD and Kebede M.  In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected vero cell monolayers.  Antimicrob Agents Chemother. 1997; 41: 578-82.

 

44.               Ives TJ and Dunn PF.  Update in the pharmacotherapies of diabetes mellitus.  Primary Care Practice.  1997; 1: 537-49.

 

45.               Sobel RA, Goldstein AO and Ives TJ.  Impact of smoking control rules on restaurants in Orange county, North Carolina.  N. Carolina Med J.  1998; 59: 288.

 

46.               Ives TJ, Deloatch KD and Ishaq K.  Implementation of an integrated, case-based, student-centered approach to learning in required courses in medicinal chemistry/pharmacotherapeutics.  Am J Pharm Educ. 1998; 62: 406-11.

 

47.               Capoccia KL, Goldstein AO, and Ives TJ.  Smoking cessation.  It’s the right time.  NC Med J.  2000; 61: 403-5.

 

48.               Ives TJ, Marston EF, Regnery RL, Butts JD, Majerus TC.  In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected Vero cell monolayers.  J Antimicrob Chemother.  2000; 45: 305-10.

 

49.               Goldstein AO, Smith KM, Ives TJ, Goldstein B.  Mycotic infections: Effective management of conditions involving the skin, hair, and nails.  Geriatrics.  2000; 55: 40-52.

 

50.               Ives TJ, Butts JD, Regnery RL, and Majerus TC.  Use of immunofluorescent antibody analysis of infected vero cell monolayers to determine in vitro susceptibilities of Bartonella elizabethae, B. henselae and B. quintana.  J Infect Dis Pharmacother.  2001; 4: 9-19.

 

51.               Ives TJ, Marston EF, Regnery RL and Butts JD.  In vitro susceptibilities of Bartonella and Rickettsia spp. to fluoroquinolone agents as determined by immunofluorescent antibody analysis of infected Vero cell monolayers.  Int J Antimicrob Agents.  2001; 18: 217-22.

 

52.               Ives TJ, Schwab UE, Ward ES and Hall H.  Disposition and activity of clarithromycin in human THP-1 monocytes during stimulated and unstimulated conditions.  Research Comm Molecular Pathol Pharmacol.  2001; 110: 191-216.

 

53.               Chetwynd EM, Ives TJ, Payne PM, Edens-Bartholomew N.  Fluconazole for post-partum candidal mastitis and infant thrush.  J Human Lact.  2002; 18: 168-71.

 

54.               Sloane PD, Zimmerman SI, Colemon LE, Ives TJ and Walsh JF.  Inappropriate medication prescribing in residential care/assisted living facilities.  J Amer Geriatr Soc.  2002; 50: 1001-11.

 

55.               Hall IH, Schwab UE, Ward ES, Butts JD, Wolford ET, and Ives TJ.  Disposition and activity of azithromycin in human THP-1 monocytes during stimulated and unstimulated conditions.  Int J Antimicrob Agents.  2002; 20: 348-60.

 

56.               Ives TJ, Schwab UE, Ward ES and Hall IH.  In vitro anti-inflammatory and immunomodulatory effects of grepafloxacin in zymogen A- or Staphylococcus aureus-stimulated human THP-1 monocytes.  J Infect Chemother.  2003; 9:134-43.

 

57.               Cooper JB, Brock TP, and Ives TJ.  Assessment of the spiritual aspect of patient care as addressed in the curricula of colleges of pharmacy.  Am J Pharm Educ.  2003; 67: 1-11.

 

58.               Hall IH, Schwab UE, Ward ES and Ives TJ.  Effects of moxifloxacin in zymogen A or S. aureus stimulated human THP-1 acute monocytes on the inflammatory process and the spread of infection.  Life Sciences.  2003; 73: 2675-85.

 

59.               Malone RM, DeWalt DA, Pignone MP, Ives TJ.  Letter.  Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure.  J Am Coll Cardiol.  2003; 42: 1334.

 

60.               Leslie SW, Beck DE, Ives TJ, Skau KA, Thompson DF, Ueda CT and Wincor MZ.  Final Report of the 2002-2003 Bylaws and Policy Development Committee.  Am J Pharm Educ.  2003; 67 (Suppl): S4-11.

 

61.               Hall IH, Schwab UE, Ward ES and Ives TJ.  Effects of alatrofloxacin, the parenteral prodrug of trovafloxacin, on human THP-1 acute monocytes on phagocytic anti-inflammatory and immunomodulation events.  Biomed Pharmacother.  2003; 57: 359-65.

 

62.               Hall IH, Schwab UE, Ward ES and Ives TJ.  Disposition and intracellular levels of moxifloxacin in human THP-1 acute monocytes in unstimulated and stimulated conditions.  Int J Antimicrob Agents.  2003; 22: 579-87.

 

63.               Hall IH, Schwab UE, Ward ES, Rublein JC, Butts JD, and Ives TJ.  Human THP-1 monocyte uptake and cellular disposition of 14C-grepafloxacin.  J Infect Chemother. 2004; 10: 11-18.

 

64.               Hall IH, Schwab UE, Ward ES and Ives TJ.  In vitro anti-inflammatory effects and immunomodulation by gemifloxacin in stimulated human THP-1 monocytes.  Pharmazie.  2004: 59: 713-9.

 

65.               ACCP White Paper: Healthy People 2010: Challenges, opportunities, and a call to action for America’s pharmacists.  Calis KA, Hutchison LC, Elliott ME, Ives TJ, Zillich AJ, Poirier T, Townsend KA, Woodall B, Feldman S, and Raebel MA.  Pharmacotherapy.  2004; 24: 1241-94.

66.               Ives TJ, Carter RA, Das SK, Gross SM, Pieper JA.  Final Report of the 2004-2005 Bylaws and Policy Development Committee.  Am J Pharm Educ.  2005; 69 (Suppl): S15.

 

67.               Chelminski PR, Ives TJ, Felix KM, Prakken SD, Miller TM, Perhac JS, Malone RM, Bryant ME, DeWalt DA, Pignone MP.  A primary care, multi-disciplinary, disease management program for opioid-treated patients with chronic non-malignant pain and a high burden of psychiatric comorbidity.  BMC Health Services Research  2005; 5:3.

 

68.               Ives TJ, Chelminski PR, Hammett-Stabler C, Malone RM, Perhac JS, Potisek NM, Shilliday BB, Dewalt DA, Pignone MP.  Predictors of opioid misuse in patients with chronic pain, a prospective cohort study.  BMC Health Services Research.  2006, 6:46.

 

69.               Potisek NM, Malone RM, Bryant Shilliday B, Ives TJ, Chelminski PR, DeWalt DA, Pignone MP.  Use of patient flow analysis to improve patient visit efficiency by decreasing wait time in primary care-based disease management programs for anticoagulation and chronic pain:  a quality improvement study.  BMC Health Services Research.  2007, 7:8.

 

70.               Malone R, Shilliday BB, Ives TJ, Pignone M.  Bridges to Excellence: Development and Evolution of a Primary Care-Based Diabetes Disease Management Program.  Diabetes Care.  2007;25:31-35.

 

71.               Onyoni EM, Ives TJ.  Assessing Implementation of Cultural Competency Content in the Curricula of Colleges of Pharmacy in the United States and Canada.  Am J Pharm Educ. 2007; 71:24.

 

72.               Primary care pharmacist practice-based research network – a descriptive report.  Dickerson LM, Kraus CK, Kuo GM,  Weber CA , Bazaldua OV, Tovar JM, Hume AL, Ives TJ, Gums JG, Carter BL.  Accepted by Am J Health-Syst Pharm. 25 pages.

 

73.               ASHP Statement on the Role of the Pharmacist in Public Health.  Submitted to American Journal of Health-System Pharmacy.  16 pages.

 

Book Reviews/Monographs

 

1.                   Ives TJ.  Identification and treatment of skin and soft-tissue infections.  Health Sciences Consortium, Chapel Hill, NC, 1984.  Monograph.

 

2.                   Ives TJ.  Family Medicine Curriculum Guide to Substance Abuse.  Fam Med.  1985; 5: 68.  Book Review.

 

3.                   Ives TJ.  Drug Consultant 1985-86.  Drug Intell Clin Pharm.  1986; 20: 315.  Book Review.

 

4.                   Ives TJ and Harris TG.  MedTeach.  Am J Hosp Pharm.  1990; 47: 450-1.  Software Review.

 

5.                   Ives TJ.  Preventing and Controlling Drug Abuse.  J Pharm Technol.  1991; 7: 216.  Book Review.

 

6.                   American Diabetes Association Policy Statement.  Insulin administration.  Diabetes Care.  1993; 16 (Suppl 2):  31-4.  Monograph.

 

7.                   Ives TJ.  AIDS & Ethics.  Edited by Reimer FM.  Am J Hosp Pharm.  1994; 51: 2220-1.  Book Review.

 

8.                   Ives TJ.  Clinical Aspects of Diabetes Mellitus.  Health Sciences Consortium, Chapel Hill, NC, 1994.  Monograph.

 

9.                   Ives TJ.  Pharmacotherapeutic Assessment of Selected Patients.  In:  Cases for Teaching Management Principles.  American Association of Colleges of Pharmacy/Glaxo, 1995.  Educational Software.

 

10.               Ives TJ.  One Minute Counselor.  A Pharmacist's Guide to Topical Corticosteroids.  APhA/ACCP. ACCP Report.  1996; 15 (10): 7-8.  Monograph.

 

11.               Dunn PF and Ives TJ.  The Role of the Pharmacist in the Management of Diabetes Mellitus.  Power-Pak Communications, Inc.  Tampa, FL, 1997.  Monograph.

 

 

Books and Book Chapters

 

1.         Chapters:  Ives TJ and Anastasio GD.  Considerations in Ambulatory Drug Therapy; and Newton WP and Ives TJ.  Office Management of Hypertension.  In:  Family Medicine:  A Study Guide for Medical Students in the Clinical Years.  1988, Williams and Wilkins.

 

2.         Chapter:  Ives TJ.  Medications for Sports Injuries.  In:  Sports Medicine: For Coaches and Trainers.  1988, University of North Carolina Press.

 

3.         Chapter:  Ives TJ.  Medications for Sports Injuries.  In:  Sports Medicine: For Coaches and Trainers, Second Edition.  1991, University of North Carolina Press.

 

4.         Chapter:  Ives TJ.  Prescription Drug Abuse and the Chemically Dependent Patient.  In:  Addictive Disorders: A Practical Guide to Treatment.  1992, Mosby Year Book Medical Publishers, Inc.

 

5.                   Chapter:  Ives TJ.  Pharmacotherapeutics.  In:  Primary Care Geriatrics:  A Case-Based Learning Program, Second Edition.  1992, Mosby Year Book Medical Publishers, Inc.

 

6.                   Chapters:  Ives TJ and Anastasio GD.  Ambulatory Pharmacotherapy; Newton WP and Ives TJ.  Hypertension; and Weir SG, Ives TJ and Dunn PF.  Diabetes Mellitus.  In:  Essentials of Family Medicine, Second Edition.  1993, Williams and Wilkins.

 

7.         Chapter:  Ives TJ.  Nonsteroidal Antiinflammatory Agents.  In:  Sports Medicine for Primary Care.  1995, Blackwell Scientific Publications, London.

 

8.         Chapter:  Ives TJ.  Pharmacotherapeutics.  In:  Primary Care Geriatrics:  A Case-Based Learning Program, Third Edition.  1996, Mosby Year Book Medical Publishers, Inc.

 

9.         Chapter:  Ives TJ, Canaday BR and Yarborough PC.  Documentation of Pharmacist Interventions. In:  Pharmacotherapy: A Patient-Focused Approach.  1996, Appleton & Lange.

 

10.        Chapter:  Ives TJ.  Dermatologic Pharmacotherapy.  In:  Practical Dermatology, Second Edition.  1997, Mosby Year Book Medical Publishers, Inc.

 

11.               Chapters:  Newton WP and Ives TJ.  Hypertension; Weir SG and Ives TJ.  Diabetes Mellitus; and

Sloane PD, Curtis P, Ebell M, Fisher M, Ives TJ and Slatt L.  Common Problems:  Overview and General Approach.  In:  Essentials of Family Medicine, Third Edition.  1998, Williams and Wilkins.

 

12.        Chapter:  Ives TJ, Canaday BR and Yarborough PC.  Documentation of Pharmacist Interventions. In:  Pharmacotherapy: A Patient-Focused Approach, Second Edition.  1998, Appleton & Lange.

 

13.        Chapter:  Ives TJ.  Primary Prevention.  In:  Pharmacotherapy Self-Assessment Program, Third Edition.  1999, American College of Clinical Pharmacy.

 

14.        Chapter:  Ives TJ, Paavola FG, and Der Marderosian AH.  Pharmacists and Public Health.  In:  Remington’s Pharmaceutical Sciences, 20th Edition.  2001, Williams & Wilkins.

 

15.               Chapter:  Ives TJ.  Photosensitivity and Burns.  In:  Applied Therapeutics, Seventh Edition.  2001, Lippincott, Williams & Wilkins.

 

16.               Chapter:  Ives TJ.  Pharmacotherapeutics.  In:  Primary Care Geriatrics:  A Case-Based Learning Program, Fourth Edition.  2001, Mosby, Inc.

 

17.               Chapter:  Ives TJ, Canaday BR and Yarborough PC.  Documentation of Pharmacist Interventions. In:  Pharmacotherapy: A Patient-Focused Approach, Third Edition.  2002, McGraw-Hill.

 

18.               Chapter:  Ives TJ.  Photosensitivity and Burns.  In:  Handbook of Applied Therapeutics.  2002, Lippincott, Williams & Wilkins.

 

19.               Chapters:  Newton WP and Ives TJ.  Hypertension; and Mintzer M, Sloane PD, and Ives TJ.  Pregnancy Prevention and Contraception.  In: Essentials of Family Medicine, Third Edition.  2002, Lippincott, Williams and Wilkins.

 

20.        Chapter:  Ives TJ.  Photosensitivity and Burns.  In:  Applied Therapeutics, Eighth Edition.  2004, Lippincott, Williams & Wilkins.

 

21.        Chapter:  Ives TJ and Der Marderosian AH.  Pharmacists and Public Health.  In:  Remington’s Pharmaceutical Sciences, 21st Edition.  2005, Lippincott, Williams & Wilkins.

 

22.        Chapter:  Canaday BR, Yarborough PC and Ives TJ.  Documentation of Pharmacist Interventions. In:  Pharmacotherapy: A Patient-Focused Approach, Sixth Edition.  2005, McGraw-Hill.

 

23.               Chapter:  Hanlon JT, Guay DRP, and Ives TJ.  Oral Analgesics: Efficacy, Mechanism of Action, Pharmacokinetics, Adverse Effects, Drug Interactions and Practical Recommendations for Use in Older Adults.  In:  Pain in the Elderly.  2005, IASP Press.

 

24.               Chapter:  Canaday BR, Yarborough PC, Malone RM, and Ives TJ.  Documentation of Pharmacist Interventions. In:  Pharmacotherapy: A Patient-Focused Approach, Seventh Edition.  To be published in 2007, McGraw-Hill.

 

25.               Chapter:  Ives TJ.  Photosensitivity and Burns.  In:  Applied Therapeutics, Ninth Edition.  To be published in 2007, Lippincott, Williams & Wilkins.

 

 

Platform or Poster Presentations/Abstracts

 

1.                   Poster:  Ives TJ.  Effect of Methyldopa on Urine Glucose Test Methods (P-132).  ASHP Midyear Clinical Meeting, Las Vegas, NV, December 3, 1979.

 

2.                   Poster:  Huff PS, Ives TJ, Almond SN and Griffin NW.  Pharmacist‑Managed Diabetes Education Service (P-16).  ASHP Midyear Clinical Meeting, Los Angeles, CA, December 6, 1982.

 

3.                   Poster:  Ives TJ and Fleming MF.  A Computerized, Duplicate Prescription Monitoring Program:  An Educational Strategy in a Family Medicine Residency Program.  131st Annual Meeting, American Pharmaceutical Association, Montreal, Canada, May 8, 1984.

 

4.                   Platform Presentation:  Ives TJ and Fleming MF.  A Computerized, Duplicate Prescription Monitoring Program: An Educational Strategy in a Family Medicine Residency Program (PS-78).  17th Annual Spring Conference, Society of Teachers of Family Medicine, Orlando, FL, May 9, 1984.

 

5.   Ãâ